(Updates with share repurchase details in the last paragraph.)
MetLife (MET) reported fiscal Q2 adjusted earnings late Wednesday of $2.43 per diluted share, up from $2.02 a year earlier.
Analysts polled by FactSet expected $2.30.
Revenue for the three months ended June 30 was $19.15 billion, up from $17.34 billion a year earlier.
Analysts expected $19.67 billion.
Also, MetLife said its board has approved a new $3 billion authorization to repurchase its common stock, which is incremental to nearly $400 million remaining under its previous authorization announced in April 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.